Ladiratuzumab Vedotin

Ladiratuzumab Vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.

Ladiratuzumab Vedotin is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).

Trade Name Ladiratuzumab Vedotin
Generic Ladiratuzumab vedotin
Ladiratuzumab vedotin Other Names Ladiratuzumab vedotin, SGN-LIV1A
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Ladiratuzumab Vedotin
Ladiratuzumab Vedotin

Innovators Monograph

You find simplified version here Ladiratuzumab Vedotin


*** Taking medicines without doctor's advice can cause long-term problems.
Share